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Methylenedioxyamphetamine (MDA) is classified as an illegal substance in many 
countries and jurisdictions around the world. Its popularity for illicit use is due to its 
stimulant and hallucinogenic effects. MDA can be synthesized from starting materials 
and reagents that are uncontrolled. These syntheses are attractive to clandestine 
laboratories as they can source large quantities of reagents without causing suspicion or 
risk of detection. Procedures for these syntheses require very little synthetic chemistry 
knowledge and are readily available online. Examination of the chemical profile of 
products from these syntheses can provide information about the starting material and 
synthetic pathway. This provides valuable information regarding linking cases, and 
tracking and limiting the supply of reagents used in clandestine laboratories. 
This thesis examines the impurity profile of two synthetic pathways to MDA, from 
helional and piperonal, both of which involve few restricted compounds and would 
therefore be ideal to clandestine chemists. Helional is a fragrant oil available for 
wholesale purchase for home perfume makers and piperonal can be extracted from 
pepper. This thesis focuses on the organic impurities from side reactions between 
precursors, intermediates, and reagents, or reaction by-products. The products of each 
step were analysed using proton nuclear magnetic resonance spectroscopy (1HNMR) and 
gas chromatography-mass spectrometry (GCMS). The results were examined to 
determine the identity of the impurities and to determine the presence of route specific 
impurities. 
The results of this investigation show the identity of multiple impurities in the free base 
product of MDA synthesized from both helional and piperonal. Piperonal and MDP2P 
were shown to be common impurities between the syntheses. Most of the impurities 
identified within the helional product had been seen and recorded previously as impurities 
from other methods and none of the impurities carried through to the HCl product. 
Therefore, no route specific impurities were identified for the synthesis of MDA from 
helional. 
  
